Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 2, 2013
Cholecystokinin and pancreatic cancer: the chicken or the egg?Jill P Smith, Travis E SolomonCellular and Molecular Gastroenterology and Hepatology|June 1, 2017
Gastrin and Gastric CancerJill P Smith, Sandeep Nadella, Nick OsborneJournal of Hepatology|February 24, 2009
Surgical management of portal hypertension in Felty's syndrome: A case report and literature reviewHeather Stock, Zakiyah Kadry, Jill P SmithCancer Immunology, Immunotherapy : CII|November 12, 2019
ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expressionJulian Burks, Alia Fleury, Sarah Livingston, et al.International Journal of Biological Sciences|March 2, 2016
The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other MalignanciesJill P Smith, Lionel K Fonkoua, Terry W MoodyThe American Journal of Gastroenterology|June 8, 2004
Amantadine therapy for chronic hepatitis C: a dose escalation studyJill P Smith, Thomas R Riley, Sandra Bingaman, et al.Pancreas|October 27, 2004
The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancerJill P Smith, Wayne B Stanley, Michael F Verderame, et al.Regulatory Peptides|January 30, 2004
Functional significance of gastrin gene expression in human cancer cellsJill P Smith, Michael F Verderame, Elizabeth N Ballard, et al.Cancer Immunology, Immunotherapy : CII|October 19, 2017
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in miceJill P Smith, Shangzi Wang, Sandeep Nadella, et al.World Journal of Gastroenterology|October 31, 2014
Novel strategies for managing pancreatic cancerWelley S Loc, Jill P Smith, Gail Matters, et al.Pageof 7